David Hallett

CIK: 0002006495

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)4 (66.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

RXRX

RECURSION PHARMACEUTICALS, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

RXRX
RECURSION PHARMACEUTICALS, INC.
Aug 17, 2026
Tax Payment(F)
Direct
26.7K shares at avg. $3.16$84K
RXRX
RECURSION PHARMACEUTICALS, INC.
May 15, 2026
Tax Payment(F)
Direct
26.7K shares at avg. $3.04$81K
RXRX
RECURSION PHARMACEUTICALS, INC.
Feb 17, 2026
Tax Payment(F)
Direct
11.9K shares at avg. $3.49$42K
RXRX
RECURSION PHARMACEUTICALS, INC.
Feb 6, 2026
Award(A)
Direct
502.1K shares-
RXRX
RECURSION PHARMACEUTICALS, INC.
Feb 6, 2026
Award(A)
Direct
24.3K shares-
RXRX
RECURSION PHARMACEUTICALS, INC.
Feb 6, 2026
Tax Payment(F)
Direct
11.4K shares at avg. $3.98$45K

		Type	Shares	Price		Ownership
Aug 17, 2026	RXRX RECURSION PHARMACEUTICALS, INC.	Tax Payment(F)	26,657	$3.16	$84,236	Direct
May 15, 2026	RXRX RECURSION PHARMACEUTICALS, INC.	Tax Payment(F)	26,657	$3.04	$81,037	Direct
Feb 17, 2026	RXRX RECURSION PHARMACEUTICALS, INC.	Tax Payment(F)	11,908	$3.49	$41,559	Direct
Feb 6, 2026	RXRX RECURSION PHARMACEUTICALS, INC.	Award(A)	502,064	-	$0	Direct
Feb 6, 2026	RXRX RECURSION PHARMACEUTICALS, INC.	Award(A)	24,254	-	$0	Direct
Feb 6, 2026	RXRX RECURSION PHARMACEUTICALS, INC.	Tax Payment(F)	11,400	$3.98	$45,372	Direct

1-6 of 6 transactions

About Hallett David

Hallett David (SEC CIK 0002006495) files insider reports with the SEC as Chief Scientific Officer of RECURSION PHARMACEUTICALS, INC. (RXRX).

Signal8 holds 5 ownership filings by Hallett David (1 Form 3, 4 Form 4), filed between Jan 9, 2026 and Aug 18, 2026. Those filings report 6 transactions, from Feb 6, 2026 to Aug 17, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Hallett David's filings is in SALT LAKE CITY, UT.

Recent filings by Hallett David

Aug 17, 2026: Tax withholding of RXRX shares (Form 4, code F).
May 15, 2026: Tax withholding of RXRX shares (Form 4, code F).
Feb 17, 2026: Tax withholding of RXRX shares (Form 4, code F).
Feb 6, 2026: Grants or awards of RXRX shares (2 lines, Form 4, code A).
Feb 6, 2026: Tax withholding of RXRX shares (Form 4, code F).

Other insiders filing for RECURSION PHARMACEUTICALS, INC. (RXRX)

Borgeson Blake, Director
HERSHBERG ROBERT, Director
Dar Zavain, Director
Li Dean Y, Director
Taylor Ben R, Chief Financial Officer
Khan Najat, CEO and President

How to read Form 4 transaction codes